vs

Side-by-side financial comparison of Maison Solutions Inc. (MSS) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $27.6M, roughly 1.0× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -67.5%, a 49.5% gap on every dollar of revenue. On growth, Outset Medical, Inc. posted the faster year-over-year revenue change (-2.0% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 1.2%).

Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

MSS vs OM — Head-to-Head

Bigger by revenue
OM
OM
1.0× larger
OM
$28.9M
$27.6M
MSS
Growing faster (revenue YoY)
OM
OM
+8.9% gap
OM
-2.0%
-10.9%
MSS
Higher net margin
MSS
MSS
49.5% more per $
MSS
-18.0%
-67.5%
OM
Faster 2-yr revenue CAGR
MSS
MSS
Annualised
MSS
42.5%
1.2%
OM

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSS
MSS
OM
OM
Revenue
$27.6M
$28.9M
Net Profit
$-5.0M
$-19.5M
Gross Margin
23.4%
42.4%
Operating Margin
-4.9%
-61.1%
Net Margin
-18.0%
-67.5%
Revenue YoY
-10.9%
-2.0%
Net Profit YoY
-1840.5%
24.0%
EPS (diluted)
$-0.23
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSS
MSS
OM
OM
Q4 25
$27.6M
$28.9M
Q3 25
$27.2M
$29.4M
Q2 25
$34.4M
$31.4M
Q1 25
$32.3M
$29.8M
Q4 24
$29.4M
$29.5M
Q3 24
$28.2M
$28.7M
Q2 24
$16.9M
$27.4M
Q1 24
$13.6M
$28.2M
Net Profit
MSS
MSS
OM
OM
Q4 25
$-5.0M
$-19.5M
Q3 25
$-1.5M
$-17.8M
Q2 25
$-287.4K
$-18.5M
Q1 25
$1.0M
$-25.8M
Q4 24
$-256.0K
$-25.6M
Q3 24
$700.9K
$-27.9M
Q2 24
$-2.8M
$-34.5M
Q1 24
$-549.0K
$-39.9M
Gross Margin
MSS
MSS
OM
OM
Q4 25
23.4%
42.4%
Q3 25
24.1%
39.4%
Q2 25
9.5%
37.8%
Q1 25
21.8%
37.2%
Q4 24
26.9%
36.5%
Q3 24
28.9%
34.3%
Q2 24
13.0%
35.7%
Q1 24
23.4%
29.2%
Operating Margin
MSS
MSS
OM
OM
Q4 25
-4.9%
-61.1%
Q3 25
0.7%
-53.7%
Q2 25
-15.9%
-53.7%
Q1 25
3.7%
-55.1%
Q4 24
3.2%
-74.2%
Q3 24
7.3%
-83.2%
Q2 24
-14.4%
-112.3%
Q1 24
-2.3%
-131.0%
Net Margin
MSS
MSS
OM
OM
Q4 25
-18.0%
-67.5%
Q3 25
-5.7%
-60.6%
Q2 25
-0.8%
-59.0%
Q1 25
3.1%
-86.7%
Q4 24
-0.9%
-87.0%
Q3 24
2.5%
-97.5%
Q2 24
-16.4%
-125.8%
Q1 24
-4.0%
-141.8%
EPS (diluted)
MSS
MSS
OM
OM
Q4 25
$-0.23
$0.33
Q3 25
$-0.08
$-1.00
Q2 25
$-0.02
$-1.04
Q1 25
$0.06
$-3.66
Q4 24
$-0.01
$-7.21
Q3 24
$0.04
$-8.02
Q2 24
$-0.16
$-9.96
Q1 24
$-0.03
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSS
MSS
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$2.6M
$96.2M
Stockholders' EquityBook value
$11.6M
$127.0M
Total Assets
$75.4M
$264.5M
Debt / EquityLower = less leverage
0.22×
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSS
MSS
OM
OM
Q4 25
$168.9M
Q3 25
$1.1M
$178.6M
Q2 25
$775.4K
$184.1M
Q1 25
$445.4K
$189.0M
Q4 24
$355.7K
$158.7M
Q3 24
$588.9K
$175.6M
Q2 24
$2.1M
$194.8M
Q1 24
$9.4M
$226.9M
Total Debt
MSS
MSS
OM
OM
Q4 25
$2.6M
$96.2M
Q3 25
$2.6M
Q2 25
$2.6M
Q1 25
Q4 24
$197.4M
Q3 24
$2.5M
Q2 24
$2.6M
Q1 24
$2.6M
Stockholders' Equity
MSS
MSS
OM
OM
Q4 25
$11.6M
$127.0M
Q3 25
$10.1M
$142.4M
Q2 25
$11.7M
$154.8M
Q1 25
$12.0M
$169.9M
Q4 24
$10.9M
$26.8M
Q3 24
$11.2M
$47.8M
Q2 24
$10.5M
$68.6M
Q1 24
$13.3M
$93.2M
Total Assets
MSS
MSS
OM
OM
Q4 25
$75.4M
$264.5M
Q3 25
$73.3M
$277.3M
Q2 25
$77.4M
$288.8M
Q1 25
$82.7M
$301.2M
Q4 24
$82.7M
$275.8M
Q3 24
$82.1M
$292.9M
Q2 24
$82.4M
$314.5M
Q1 24
$44.2M
$346.2M
Debt / Equity
MSS
MSS
OM
OM
Q4 25
0.22×
0.76×
Q3 25
0.26×
Q2 25
0.22×
Q1 25
Q4 24
7.36×
Q3 24
0.23×
Q2 24
0.24×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSS
MSS
OM
OM
Operating Cash FlowLast quarter
$-1.7M
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSS
MSS
OM
OM
Q4 25
$-1.7M
$-9.5M
Q3 25
$1.1M
$-6.3M
Q2 25
$-1.6M
$-4.8M
Q1 25
$1.7M
$-25.7M
Q4 24
$1.1M
$-16.5M
Q3 24
$3.6M
$-20.6M
Q2 24
$-2.6M
$-33.3M
Q1 24
$-1.4M
$-45.9M
Free Cash Flow
MSS
MSS
OM
OM
Q4 25
$-9.7M
Q3 25
$-6.5M
Q2 25
$-5.1M
Q1 25
$-25.8M
Q4 24
$-16.5M
Q3 24
$-21.0M
Q2 24
$-33.5M
Q1 24
$-46.3M
FCF Margin
MSS
MSS
OM
OM
Q4 25
-33.7%
Q3 25
-22.0%
Q2 25
-16.3%
Q1 25
-86.7%
Q4 24
-56.1%
Q3 24
-73.1%
Q2 24
-122.2%
Q1 24
-164.3%
Capex Intensity
MSS
MSS
OM
OM
Q4 25
0.8%
Q3 25
0.5%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.1%
Q3 24
1.4%
Q2 24
0.4%
Q1 24
1.3%
Cash Conversion
MSS
MSS
OM
OM
Q4 25
Q3 25
Q2 25
Q1 25
1.66×
Q4 24
Q3 24
5.12×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSS
MSS

Perishables$14.4M52%
Nonperishables$13.2M48%

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons